Source: EN24
In Senegal, the health authorities established on Saturday September 5th an assessment of the results of the measures taken to fight against the spread of Covid-19 in the country, after six months of pandemic.
The number of coronavirus cases has been declining for several weeks in Senegal. But “the virus is still there” warns the Minister of Health, Abdoulaye Diouf Sarr. The watchwords are therefore always the same: respect for barrier measures and prevention.
The objective is to avoid a resumption of the Covid-19 epidemic while millions of people will come together during the next religious ceremonies. Professor Moussa Seydi, head of the infectious diseases department at Fann hospital in Dakar, confirmed that the use of hydroxychloroquine with the antibiotic azithromycin is effective for early stage cases.
However, this treatment works less well for severe cases. A new scientific study has therefore been underway since August 14 to assess the effectiveness of an anticoagulant and anti-inflammatory drug, which gives much hope in the improvement of severe forms.
The director of the Institut Pasteur, Amadou Sall, also announced that rapid diagnostic tests are in the pilot phase in six localities in the country. Evaluations are expected in the coming weeks in order to extend its use at the national level. According to figures from the African Union, Senegal has experienced 287 deaths from the coronavirus for nearly 14,000 cases.
Related:
Senegal says hydroxychloroquine virus treatment is promising
Nigeria: Chloroquine / hydroxychloroquine potent for COVID-19 prevention , says NAFDAC
Nigeria: NAFDAC To Continue Hydroxychloroquine Trial Despite WHO’s Directive